-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 JFISPKCScoTBHDCwZW4NrfHlMizHDLHeH9jl2XedZp37unni6IUNc9mS/luK43be
 bdlYF0BE5vybPyClhLKl8g==

<SEC-DOCUMENT>0000012208-07-000008.txt : 20070222
<SEC-HEADER>0000012208-07-000008.hdr.sgml : 20070222
<ACCEPTANCE-DATETIME>20070222164202
ACCESSION NUMBER:		0000012208-07-000008
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20061231
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20070222
DATE AS OF CHANGE:		20070222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO RAD LABORATORIES INC
		CENTRAL INDEX KEY:			0000012208
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				941381833
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-07928
		FILM NUMBER:		07642744

	BUSINESS ADDRESS:	
		STREET 1:		1000 ALFRED NOBEL DR
		CITY:			HERCULES
		STATE:			CA
		ZIP:			94547
		BUSINESS PHONE:		5107247000
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8kcover.htm
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>UNITED STATES</TITLE>
<META NAME="author" CONTENT="Tom Brida">
<META NAME="date" CONTENT="02/22/2007">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:691.2px"><P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>UNITED STATES</B></P>
<P style="margin:0px" align=center><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P style="margin:0px" align=center><B>Washington, D.C. 20549</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="line-height:21.333px; margin:0px; font-size:18.667px" align=center><B>FORM 8-K</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>CURRENT REPORT</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px" align=center><B>Date of Report: February 22, 2007</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(Date of earliest event reported)</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; font-size:18.667px" align=center><B>BIO-RAD LABORATORIES, INC.</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(Exact name of registrant as specified in its charter)</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>Commission File Number: 1-7928</B></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0 align=center><TR><TD width=360></TD><TD width=7.133></TD><TD width=352.8></TD></TR>
<TR><TD width=360><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD><TD valign=bottom width=7.133><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD><TD width=352.8><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=360><P style="margin:0px" align=center><B>Delaware</B></P>
</TD><TD valign=bottom width=7.133><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD><TD valign=top width=352.8><P style="margin:0px" align=center><B>94-1381833</B></P>
</TD></TR>
<TR><TD valign=top width=360><P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(State or other jurisdiction of</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>incorporation or organization)</B></P>
</TD><TD valign=bottom width=7.133><P style="margin:0px; font-size:10.667px">&nbsp;</P>
</TD><TD valign=top width=352.8><P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(I.R.S. Employer</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>Identification No.)</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<P style="margin:0px" align=center><B>1000 Alfred Nobel Dr.</B></P>
<P style="margin:0px" align=center><B>Hercules, California 94547</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(Address of principal executive offices, including zip code)</B></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<P style="margin:0px" align=center><B>(510) 724-7000</B></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px" align=center><B>(Registrant&#146;s telephone number, including area code)</B></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-top:4px; border-top:1px solid #7F0000"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:13.333px; margin:0px; font-size:10.667px">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=28.8></TD><TD width=562.733></TD></TR>
<TR><TD valign=top width=28.8><P style="line-height:13.333px; margin:0px; font-family:Wingdings; font-size:10.667px"><FONT FACE="Wingdings">&#168;</FONT></P>
</TD><TD valign=top width=562.733><P style="line-height:13.333px; margin:0px; font-size:10.667px"><FONT FACE="Times New Roman">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=28.8></TD><TD width=565.6></TD></TR>
<TR><TD valign=top width=28.8><P style="line-height:13.333px; margin:0px; font-family:Wingdings; font-size:10.667px"><FONT FACE="Wingdings">&#168;</FONT></P>
</TD><TD valign=top width=565.6><P style="line-height:13.333px; margin:0px; font-size:10.667px"><FONT FACE="Times New Roman">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=28.8></TD><TD width=616.267></TD></TR>
<TR><TD valign=top width=28.8><P style="line-height:13.333px; margin:0px; font-family:Wingdings; font-size:10.667px"><FONT FACE="Wingdings">&#168;</FONT></P>
</TD><TD valign=top width=616.267><P style="line-height:13.333px; margin:0px; font-size:10.667px"><FONT FACE="Times New Roman">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:10.667px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=28.8></TD><TD width=615></TD></TR>
<TR><TD valign=top width=28.8><P style="line-height:13.333px; margin:0px; font-family:Wingdings; font-size:10.667px"><FONT FACE="Wingdings">&#168;</FONT></P>
</TD><TD valign=top width=615><P style="line-height:13.333px; margin:0px; font-size:10.667px"><FONT FACE="Times New Roman">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px; page-break-before:always"><B>&nbsp;</B></P>
<P style="margin:0px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=83.333></TD><TD width=285.933></TD></TR>
<TR><TD valign=top width=83.333><P style="margin:0px" align=justify><B>ITEM 2.02</B></P>
</TD><TD valign=top width=285.933><P style="margin:0px"><B>Results of Operations and Financial Condition</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px">On February 22, 2007, Bio-Rad Laboratories, Inc. announced its results of operations and financial condition as of and for the year ended December 31, 2006. &nbsp;A copy of the press release is furnished as Exhibit 99.1 to this report.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed to be &#147;filed&#148; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. </P>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=83.333></TD><TD width=492.667></TD></TR>
<TR><TD valign=top width=83.333><P style="margin:0px"><B>ITEM 9.01</B></P>
</TD><TD valign=top width=492.667><P style="margin:0px"><B>Financial Statements and Exhibits</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=60></TD><TD width=24></TD><TD width=497.533></TD></TR>
<TR><TD width=60><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=24><P style="margin:0px">&nbsp;</P>
</TD><TD width=497.533><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=bottom width=60><P style="margin:0px"><B>Exhibit</B></P>
<P style="margin:0px"><B>Number&nbsp;</B></P>
</TD><TD valign=bottom width=24><P style="margin:0px">&nbsp;</P>
</TD><TD style="border-bottom:1px solid #000000" valign=bottom width=497.533><P style="margin:0px"><BR></P>
<P style="margin:0px"><B>Description</B></P>
</TD></TR>
<TR><TD valign=top width=60><P style="margin-top:2.2px; margin-bottom:0px" align=right>99.1&nbsp;</P>
</TD><TD valign=bottom width=24><P style="margin-top:2.2px; margin-bottom:0px">&nbsp;</P>
</TD><TD valign=bottom width=497.533><P style="margin-top:2.2px; margin-bottom:0px">Press release of Bio-Rad Laboratories, Inc. dated February 22, 2007</P>
</TD></TR>
</TABLE>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR>
<BR></P>
<P style="margin:0px; page-break-before:always" align=center><B>SIGNATURES</B></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<P style="margin:0px">&nbsp;&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=50.867></TD><TD width=136.333></TD><TD width=29.467></TD><TD width=29.467></TD><TD width=4></TD><TD width=185.667></TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=189.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=189.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=219.133 colspan=3><P style="margin:0px">BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=189.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=50.867><P style="margin:0px">Date:</P>
</TD><TD style="border-bottom:1px solid #000000" width=136.333><P style="margin:0px">February 22, 2007</P>
</TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="margin:0px">By:</P>
</TD><TD valign=bottom width=189.667 colspan=2><P style="margin:0px">&nbsp;<U>/s/ Christine A. Tsingos</U></P>
</TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=29.467><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=185.667><P style="margin:0px">Christine A. Tsingos<U> </U></P>
</TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=136.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=185.667><P style="margin:0px">Vice President,</P>
</TD></TR>
<TR><TD valign=top width=50.867><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=136.333><P style="margin:0px">&nbsp;</P>
</TD><TD valign=top width=29.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=29.467><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=4><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=185.667><P style="margin:0px">Chief Financial Officer</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<A NAME="id_11"></A><A NAME="id_12"></A><P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>EXHIBIT INDEX</B></P>
<P style="margin:0px">&nbsp;</P>
<TABLE style="font-size:13.333px" cellspacing=0 align=center><TR><TD width=34.2></TD><TD width=28.267></TD><TD width=513.533></TD></TR>
<TR><TD width=34.2><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=28.267><P style="margin:0px">&nbsp;</P>
</TD><TD width=513.533><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=bottom width=34.2><P style="line-height:12px; margin:0px; font-size:9.333px"><B>Exhibit</B></P>
<P style="line-height:12px; margin:0px; font-size:9.333px"><B>Number</B></P>
</TD><TD valign=bottom width=28.267><P style="margin:0px; font-size:9.333px">&nbsp;</P>
</TD><TD style="border-bottom:1px solid #000000" valign=bottom width=513.533><P style="line-height:12px; margin:0px; font-size:9.333px"><B>Description</B></P>
</TD></TR>
<TR><TD valign=top width=34.2><P style="margin:0px">99.1</P>
</TD><TD valign=bottom width=28.267><P style="margin:0px">&nbsp;</P>
</TD><TD valign=bottom width=513.533><P style="margin:0px">Press release of Bio-Rad Laboratories, Inc. dated February 22, 2007</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
</DIV></BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1 CHARTER
<SEQUENCE>2
<FILENAME>ex991123106.htm
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Exhibit 99</TITLE>
<META NAME="author" CONTENT="Stephanie Trudrung">
<META NAME="date" CONTENT="01/29/2007">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:643.2px"><P style="line-height:24.667px; margin:0px; font-size:14.667px" align=right><B><U>Exhibit 99.1</U></B></P>
<P style="margin:0px; padding-right:43.2px">FOR IMMEDIATE RELEASE</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center>BIO-RAD REPORTS FOURTH QUARTER AND FULL YEAR </P>
<P style="margin:0px" align=center>2006 FINANCIAL RESULTS</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px">HERCULES, CA &#150; February 22, 2007 &#150; Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced financial results today for the fourth quarter and fiscal year ended December 31, 2006. <FONT COLOR=#0000FF>&nbsp;</FONT></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px">Fourth-quarter revenues were $343.1 million, up 11.6% compared to $307.3 million reported for the fourth quarter of 2005.<FONT COLOR=#0000FF> </FONT>On a currency-neutral basis, revenues increased<FONT COLOR=#0000FF> </FONT>7.6%<FONT COLOR=#0000FF> </FONT>compared to the same period last year.<FONT COLOR=#0000FF> </FONT>This growth was primarily organic across product areas in both the Life Science and Clinical Diagnostics segments complemented by two acquisitions completed during the fourth quarter. </P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px">Income from continuing operations for the fourth quarter<FONT COLOR=#0000FF> </FONT>was $16.6 million compared to<FONT COLOR=#0000FF> </FONT>$13.5 million during the fourth quarter last year.<FONT COLOR=#0000FF> </FONT>Fourth-quarter basic earnings from continuing operations were $0.63 per share, or $0.61 per share on a diluted basis, compared to $0.51 and $0.50, respectively, during the same period last year.<FONT COLOR=#0000FF> </FONT>Fourth-quarter<FONT COLOR=#0000FF> </FONT>gross margin<FONT COLOR=#0000FF> </FONT>from continuing operations was 54.1%<FONT COLOR=#0000FF> </FONT>compared to<FONT COLOR=#0000FF> </FONT>52.9%<FONT COLOR=#0000FF> </FONT>in the same period last year.<FONT COLOR=#0000FF> </FONT></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px">For the full year, Company sales grew by 7.9% to $1,273.9 million compared to $1,181.0 in 2005. Normalizing for the impact of currency effects, growth was 7.7%. Favorable impacts on year-to-date figures for 2006 include a Russian tender won in the first quarter for laboratory equipment as well as one-time additional revenue of $11.7 million resulting from a licensing settlement agreement reached with bioM&#233;rieux SA. </P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px">Full-year gross margin from continuing operations was 55.9%, up from last year&#146;s figure of 54.7%. &nbsp;&nbsp;&nbsp;</P>
<P style="line-height:21.333px; margin:0px">Year-over-year income from continuing operations grew 33.1% to $103.3 million, or $3.92 per share, from $77.6 million, or $2.98 per share in 2005. </P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px">&#147;2006 was a year of continued progress on many fronts,&#148; said Norman Schwartz, Bio-Rad President and Chief Executive Officer. &#147;The year brought increased organic growth within our core businesses, expansion of our product lines through new product introductions and strategic acquisitions, and infrastructure improvements. As a result, Bio-Rad is well-positioned in key market areas and has a strengthened foundation for the long term.&#148; &nbsp;</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px" align=center><BR></P>
<P style="line-height:21.333px; margin:0px" align=center><BR></P>
<P style="line-height:21.333px; margin:0px" align=center><BR></P>
<P style="line-height:21.333px; margin:0px" align=center><BR></P>
<P style="line-height:21.333px; margin:0px; padding-right:43.2px" align=center>(more)</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; page-break-before:always"><BR></P>
<P style="line-height:21.333px; margin:0px; padding-right:43.2px">Bio-Rad Reports&#133; </P>
<P style="line-height:22.667px; margin:0px; padding-right:43.2px">Page 2</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:22.667px; margin:0px">Life Science </P>
<P style="line-height:21.333px; margin:0px">The Life Science segment net sales for the quarter were $159.0 million,<FONT COLOR=#0000FF> </FONT>up<FONT COLOR=#0000FF> </FONT>13.0%<FONT COLOR=#0000FF> </FONT>compared to the fourth quarter of last year. On a currency-neutral basis, segment sales increased by 8.8%<FONT COLOR=#0000FF>. </FONT>Full-year reported revenues were<FONT COLOR=#0000FF> </FONT>$575.6 million for the segment, up 4.7% over the prior year,<FONT COLOR=#0000FF> </FONT>or<FONT COLOR=#0000FF> </FONT>4.6% on a currency-neutral basis.<FONT COLOR=#0000FF> </FONT>Performance in the Life Science segment was boosted<FONT COLOR=#0000FF> </FONT>by a number of factors including significant growth<FONT COLOR=#0000FF> </FONT>in protein expression analysis,<FONT COLOR=#0000FF> </FONT>process chromatography, and amplification reagents.<FONT COLOR=#0000FF> </FONT>In addition, the segment benefited from the purchase of Ciphergen Biosystems, Inc.&#146;s life science business including worldwide technology right
s to Ciphergen&#146;s Surface Enhanced Laser Desorption/Ionization (SELDI) technology and ProteinChip<SUP>&#174;</SUP> System<FONT COLOR=#0000FF>. </FONT>These results were somewhat tempered by reduced BSE (bovine spongiform encephalopathy) revenue and slowed life science markets in the U.S. and Japan. </P>
<P style="margin:0px"><BR></P>
<P style="line-height:22.667px; margin:0px">Clinical Diagnostics</P>
<P style="line-height:21.333px; margin:0px">The Clinical Diagnostics segment reported net sales of $180.1 million for the quarter, up<FONT COLOR=#0000FF> </FONT>10.6% compared to the prior-year quarter, or 6.5% excluding currency effects. Full-year segment sales were $684.9 million, a<FONT COLOR=#0000FF> </FONT>10.8% increase compared to<FONT COLOR=#0000FF> </FONT>2005 results,<FONT COLOR=#0000FF> </FONT>or 10.4% excluding currency effects. These results were largely due to continued growth across all product lines, most notably blood virus products as well as MRSASelect<SUP>&#8482;</SUP> chromogenic media, which detects Methicillin-resistant Staphylococcus aureus.<FONT COLOR=#0000FF> </FONT>Sales of quality controls product lines were also up significantly during the quarter. During the quarter, the segment completed the purchase of Blackhawk BioSystems, Inc., a manufacturer of infectious disease quality control products. </P>
<P style="margin:0px"><BR></P>
<P style="line-height:22.667px; margin:0px">2006 Full Year Review</P>
<P style="line-height:24px; margin-top:0px; margin-bottom:-24px; padding-left:48px; text-indent:-24px; font-family:Symbol"><FONT FACE="Symbol">&#183;</FONT></P>
<P style="line-height:21.333px; margin:0px; padding-left:48px"><FONT FACE="Times New Roman">Full-year Company sales grew by 7.9% to $1,273.9 million.</FONT></P>
<P style="line-height:24px; margin-top:0px; margin-bottom:-24px; padding-left:48px; text-indent:-24px; font-family:Symbol"><FONT FACE="Symbol">&#183;</FONT></P>
<P style="line-height:21.333px; margin:0px; padding-left:48px"><FONT FACE="Times New Roman">Year-over-year income from continuing operations grew by 33.1% to $103.3 million from $77.6 million in 2005.</FONT></P>
<P style="line-height:24px; margin-top:0px; margin-bottom:-24px; padding-left:48px; text-indent:-24px; font-family:Symbol"><FONT FACE="Symbol">&#183;</FONT></P>
<P style="line-height:21.333px; margin:0px; padding-left:48px"><FONT FACE="Times New Roman">In February of 2006, the Company settled litigation and resumed U.S. sales of certain thermal cycling products.</FONT></P>
<P style="line-height:24px; margin-top:0px; margin-bottom:-24px; padding-left:48px; text-indent:-24px; font-family:Symbol"><FONT FACE="Symbol">&#183;</FONT></P>
<P style="line-height:21.333px; margin:0px; padding-left:48px"><FONT FACE="Times New Roman">In April, the Company announced that it had signed a multi-year agreement in which Premier, one of the largest group purchasing organizations in the U.S., had agreed to a 3-year sole-source contract with Bio-Rad covering diabetes monitoring instrumentation and products. </FONT></P>
<P style="line-height:24px; margin-top:0px; margin-bottom:-24px; padding-left:48px; text-indent:-24px; font-family:Symbol"><FONT FACE="Symbol">&#183;</FONT></P>
<P style="line-height:21.333px; margin:0px; padding-left:48px"><FONT FACE="Times New Roman">As a result of a settlement reached with bioM&#233;rieux SA, in the second quarter Bio-Rad reported additional revenue of $11.7 million in royalties and licensing fees. </FONT></P>
<P style="line-height:24px; margin-top:0px; margin-bottom:-24px; padding-left:48px; text-indent:-24px; font-family:Symbol"><FONT FACE="Symbol">&#183;</FONT></P>
<P style="line-height:21.333px; margin:0px; padding-left:48px"><FONT FACE="Times New Roman">Also during the second quarter, the segment launched a number of products including Platelia</FONT><SUP>&#174; </SUP>Dengue NS1 Ag Assay for dengue screening; a diagnostic test for celiac disease, an </P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; page-break-before:always"><BR></P>
<P style="margin:0px" align=center>(more)</P>
<P style="margin:0px">Bio-Rad Reports&#8230; </P>
<P style="margin:0px">Page 3</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; padding-left:48px">autoimmune disorder; and a new Rack Loader for use in conjunction with the D-10<SUP>&#8482; &nbsp;</SUP>Hemoglobin Testing System, which expanded the sample handling capacity of the system to 50 samples per run. &nbsp;</P>
<P style="line-height:24px; margin-top:0px; margin-bottom:-24px; padding-left:48px; text-indent:-24px; font-family:Symbol"><FONT FACE="Symbol">&#183;</FONT></P>
<P style="line-height:21.333px; margin:0px; padding-left:48px"><FONT FACE="Times New Roman">In September, Bio-Rad announced the availability of the ProteOn</FONT><SUP>&#8482; &nbsp;</SUP>XPR36 Protein Interaction Array System. In addition, the Company announced that it had completed the purchase of the diagnostics business of Provalis plc, a provider of point of care diagnostic products for chronic disease management of diabetes and osteoporosis. &nbsp;</P>
<P style="line-height:24px; margin-top:0px; margin-bottom:-24px; padding-left:48px; text-indent:-24px; font-family:Symbol"><FONT FACE="Symbol">&#183;</FONT></P>
<P style="line-height:21.333px; margin:0px; padding-left:48px"><FONT FACE="Times New Roman">In October, Bio-Rad announced that it had acquired Blackhawk BioSystems, Inc., a manufacturer of quality control products used in laboratories that perform infectious disease testing procedures.</FONT></P>
<P style="line-height:24px; margin-top:0px; margin-bottom:-24px; padding-left:48px; text-indent:-24px; font-family:Symbol"><FONT FACE="Symbol">&#183;</FONT></P>
<P style="line-height:21.333px; margin:0px; padding-left:48px"><FONT FACE="Times New Roman">In November, Bio-Rad completed the purchase of Ciphergen Biosystems, Inc.&#146;s life science business including worldwide technology rights to Ciphergen&#146;s Surface Enhanced Laser Desorption/Ionization (SELDI) technology and ProteinChip</FONT><SUP>&#174;</SUP> System.</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px">Management will discuss these results in a conference call at 2 p.m. Pacific Standard Time (5 p.m. Eastern Standard Time) February 22, 2007.<FONT COLOR=#0000FF> </FONT>Interested parties can access the call by dialing 800-265-0241 (in the U.S.), or<FONT COLOR=#0000FF> </FONT>617-847-8704 (international),<FONT COLOR=#0000FF> </FONT>access number 86039052.<FONT COLOR=#0000FF> </FONT>The live webcast can be accessed at http://www.bio-rad.com. A replay of the call will be available at<FONT COLOR=#0000FF> </FONT>888-286-8010 (in the U.S.), or 617-801-6888 (international), access number 21671774, for seven days following the call and the webcast can be accessed at http://www.bio-rad.com for 30 days.</P>
<P style="margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px">About Bio-Rad</P>
<P style="line-height:21.333px; margin:0px">Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), has remained at the center of scientific discovery for more than 50 years manufacturing and distributing a broad range of products for the life science research and clinical diagnostics markets. The company is renowned worldwide among hospitals, universities, major research institutions as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 85,000 research and industry customers worldwide through its global network of operations. The company employs over 5,000 people globally and had revenues of nearly $1.3 billion in 2006. For more information, visit www.bio-rad.com. </P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">Various statements made within this press release may constitute &#148;forward-looking statements&#148; for the purposes of the Securities and Exchange Commission&#146;s &#147;safe harbor&#148; provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. &nbsp;The forward-looking statements contained herein involve risks and uncertainties that could cause results to differ materially from the Company&#146;s expectation.</P>
<P style="margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px">For more information contact:</P>
<P style="line-height:21.333px; margin:0px">Christine Tsingos, Vice President and Chief Financial Officer, or</P>
<P style="line-height:21.333px; margin:0px">Ron Hutton, Treasurer</P>
<P style="line-height:21.333px; margin:0px">Bio-Rad Laboratories, Inc.</P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px; page-break-before:always">510-724-7000</P>
<P style="line-height:21.333px; margin:0px">investor_relations@bio-rad.com </P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin:0px"><BR></P>
<P style="line-height:21.333px; margin-top:0px; margin-bottom:8px"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=320.333></TD><TD width=71.933></TD><TD width=12></TD><TD width=71.933></TD><TD width=12></TD><TD width=77.933></TD><TD width=12.4></TD><TD width=76.267></TD></TR>
<TR><TD valign=top width=654.8 colspan=8><P style="margin:0px; font-family:Arial" align=center><FONT FACE="Arial">BIO-RAD LABORATORIES, INC.</FONT></P>
</TD></TR>
<TR><TD valign=top width=654.8 colspan=8><P style="margin:0px; font-family:Arial" align=center>Condensed Consolidated Statements of Income</P>
</TD></TR>
<TR><TD valign=top width=654.8 colspan=8><P style="margin:0px; font-family:Arial" align=center>(In thousands, except per share data)</P>
</TD></TR>
<TR><TD valign=top width=654.8 colspan=8><P style="margin:0px; font-family:Arial" align=center>(Unaudited)</P>
</TD></TR>
<TR><TD valign=top width=320.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=155.867 colspan=3><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=12><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=166.6 colspan=3><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=320.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=155.867 colspan=3><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>Three Months Ended</P>
</TD><TD valign=top width=12><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=166.6 colspan=3><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>Twelve Months Ended</P>
</TD></TR>
<TR><TD width=320.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=155.867 colspan=3><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>December 31,</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=166.6 colspan=3><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>December 31,</P>
</TD></TR>
<TR><TD width=320.333><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>2006</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>2005</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>2006</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>2005</P>
</TD></TR>
<TR><TD width=320.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Net sales</P>
</TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;343,081&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;307,287&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 1,273,930&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 1,180,985&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Cost of good sold</P>
</TD><TD style="border-bottom:1px solid #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>157,524&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>144,662&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>561,394&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>534,499&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Gross profit</P>
</TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>185,557&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>162,625&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>712,536&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>646,486&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom width=320.333><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=12><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=12><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=76.267><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=bottom width=320.333><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Selling, general and administrative expense</P>
</TD><TD valign=bottom width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>122,463&nbsp;</P>
</TD><TD valign=bottom width=12><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>109,626&nbsp;</P>
</TD><TD valign=bottom width=12><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>438,949&nbsp;</P>
</TD><TD valign=bottom width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=bottom width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>416,084&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Product research and development expense</P>
</TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>33,326&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>31,109&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>123,376&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>115,104&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Purchased in-process research and </P>
</TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="margin:0px; font-family:Arial; font-size:12px" align=right>&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="margin:0px; font-family:Arial; font-size:12px" align=right>&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">development expense</P>
</TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>4,100&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>4,100&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Impairment expenses</P>
</TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>19,770&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>19,770&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Interest expense</P>
</TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>7,911&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>8,272&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>32,022&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>32,643&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Foreign exchange (gains) losses, net</P>
</TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>94&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(232)</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>1,053&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(1,528)</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Other (income) expense, net</P>
</TD><TD style="border-bottom:1px solid #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(6,182)</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(14,925)</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(28,991)</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(28,958)</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Income from continuing operations before taxes</P>
</TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>23,845&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>9,005&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>142,027&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>93,371&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Provision for income taxes</P>
</TD><TD style="border-bottom:1px solid #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>7,196&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(4,447)</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>38,764&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>15,792&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Income from continuing operations</P>
</TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>16,649&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>13,452&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>103,263&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>77,579&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Discontinued operations</P>
</TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>3,974&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Net income</P>
</TD><TD style="border-top:1px solid #000000; border-bottom:2.667px double #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;16,649&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000; border-bottom:2.667px double #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;13,452&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000; border-bottom:2.667px double #000000" width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;103,263&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000; border-bottom:2.667px double #000000" width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;81,553&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Basic earnings per share:</P>
</TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Continuing operations</P>
</TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$0.63&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 0.51&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 3.92&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 2.98&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Discontinued operations</P>
</TD><TD style="border-bottom:1px solid #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>0.15&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Net income</P>
</TD><TD style="border-bottom:2.667px double #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 0.63&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 0.51&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 3.92&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 3.13&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Weighted average common shares</P>
</TD><TD style="border-bottom:2.667px double #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>26,478&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>26,203&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>26,376&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>26,063&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Diluted earnings per share:</P>
</TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Continuing operations</P>
</TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 0.61&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 0.50&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 3.83&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 2.91&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Discontinued operations</P>
</TD><TD style="border-bottom:1px solid #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>0.15&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Net income</P>
</TD><TD style="border-bottom:2.667px double #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 0.61&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 0.50&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 3.83&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ 3.06&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=320.333><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Weighted average common shares</P>
</TD><TD style="border-bottom:2.667px double #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>27,086&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=71.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>26,770&nbsp;</P>
</TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=77.933><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>26,949&nbsp;</P>
</TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=76.267><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>26,662&nbsp;</P>
</TD></TR>
<TR><TD width=320.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=320.333><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=71.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12><P style="font-size:2pt">&nbsp;</P></TD><TD width=77.933><P style="font-size:2pt">&nbsp;</P></TD><TD width=12.4><P style="font-size:2pt">&nbsp;</P></TD><TD width=76.267><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD width=654.8 colspan=8><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin:0px; page-break-before:always"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=381.733></TD><TD width=79></TD><TD width=15.733></TD><TD width=79></TD></TR>
<TR><TD valign=top width=555.467 colspan=4><P style="margin:0px; font-family:Arial" align=center>BIO-RAD LABORATORIES, INC.</P>
<P style="margin:0px; font-family:Arial; font-size:12px" align=center>Condensed Consolidated Balance Sheets</P>
<P style="margin:0px; font-family:Arial; font-size:12px" align=center>(In thousands)</P>
<P style="margin:0px; font-family:Arial; font-size:12px" align=center>(Unaudited)</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=173.733 colspan=3><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=79><P style="margin:0px; font-family:Arial; font-size:12px" align=right>December 31,&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=79><P style="margin:0px; font-family:Arial; font-size:12px" align=right>December 31,&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=79><P style="margin:0px; font-family:Arial; font-size:12px" align=center>2006</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=79><P style="margin:0px; font-family:Arial; font-size:12px" align=center>2005</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=79><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=79><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; font-family:Arial; font-size:12px">Current Assets:</P>
</TD><TD valign=top width=79><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=79><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Cash and cash equivalents </P>
</TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;223,607&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;296,716&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Restricted cash</P>
</TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>36,138&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Short-term investments</P>
</TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>264,473&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>116,343&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Accounts receivable, net </P>
</TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>292,970&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>247,192&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="line-height:14.667px; margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Inventories, net </P>
</TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>253,045&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>212,342&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Other current assets</P>
</TD><TD style="border-bottom:1px solid #000000" width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>95,682&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>99,480&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; text-indent:28.8px; font-family:Arial; font-size:12px">Total current assets </P>
</TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>1,129,777&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>1,008,211&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; font-family:Arial; font-size:12px">Net property, plant and equipment </P>
</TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>189,627&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>180,258&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; font-family:Arial; font-size:12px">Goodwill </P>
</TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>119,492&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>113,276&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; font-family:Arial; font-size:12px">Purchased intangibles, net</P>
</TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>44,605&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>28,449&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; font-family:Arial; font-size:12px">Other assets </P>
</TD><TD style="border-bottom:1px solid #000000" width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>112,667&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>96,388&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; text-indent:28.8px; font-family:Arial; font-size:12px">Total assets</P>
</TD><TD style="border-bottom:2.667px double #000000" width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;1,596,168&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;1,426,582&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=79><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=79><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; font-family:Arial; font-size:12px">Current liabilities:</P>
</TD><TD valign=top width=79><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=79><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Notes payable and current maturities of long-term debt</P>
</TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3,042&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3,341&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Accounts payable</P>
</TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>83,411&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>72,950&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Accrued payroll and employee benefits</P>
</TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>92,101&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>81,076&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Sales, income and other taxes payable</P>
</TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>19,949&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>15,841&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; text-indent:19.2px; font-family:Arial; font-size:12px">Other current liabilities</P>
</TD><TD style="border-bottom:1px solid #000000" width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>121,030&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>146,035&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; text-indent:28.8px; font-family:Arial; font-size:12px">Total current liabilities</P>
</TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>319,533&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>319,243&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; font-family:Arial; font-size:12px">Long-term debt, net of current maturities</P>
</TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>425,625&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>425,687&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; font-family:Arial; font-size:12px">Other long-term liabilities</P>
</TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>31,472&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>23,678&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; font-family:Arial; font-size:12px">Stockholders&#146; equity</P>
</TD><TD style="border-bottom:1px solid #000000" width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>819,538&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>657,974&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="margin:0px; text-indent:28.8px; font-family:Arial; font-size:12px">Total liabilities and stockholders&#146; equity </P>
</TD><TD style="border-bottom:2.667px double #000000" width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;1,596,168&nbsp;</P>
</TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=79><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;1,426,582&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=381.733><P style="font-size:2pt">&nbsp;</P></TD><TD width=79><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.733><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=79><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><BR>
<BR></P>
<P style="margin:0px; page-break-before:always" align=center><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=406.467></TD><TD width=99.6></TD><TD width=15.667></TD><TD width=1.733></TD><TD width=97.933></TD></TR>
<TR><TD valign=top width=621.4 colspan=5><P style="margin:0px; font-family:Arial" align=center>BIO-RAD LABORATORIES, INC.</P>
</TD></TR>
<TR><TD valign=top width=621.4 colspan=5><P style="margin:0px; font-family:Arial" align=center>Condensed Consolidated Statements of Cash Flows</P>
</TD></TR>
<TR><TD valign=top width=621.4 colspan=5><P style="margin:0px; font-family:Arial" align=center>(in thousands)</P>
</TD></TR>
<TR><TD valign=top width=621.4 colspan=5><P style="margin:0px; font-family:Arial" align=center>(Unaudited)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=17.4 colspan=2><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=97.933><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=214.933 colspan=4><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>Twelve Months Ended</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=214.933 colspan=4><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=center>December 31,</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=99.6><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>2006&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>2005&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Cash flows from operating activities:</P>
</TD><TD valign=top width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Cash received from customers</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,247,779&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,166,711&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Cash paid to suppliers and employees</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(1,058,977)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(1,003,264)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Interest paid</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(31,049)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(31,334)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Income tax payments</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(16,072)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(39,597)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Litigation settlement related to MJ acquisition</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(46,981)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Other operating activities</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>23,529&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>15,768&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Net cash provided by operating activities</P>
</TD><TD style="border-top:1px solid #000000" width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>118,229&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000" width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>108,284&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Cash flows from investing activities:</P>
</TD><TD width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Capital expenditures, net</P>
</TD><TD width=99.6><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(52,987)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(36,055)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Receipt (payment) of restricted cash</P>
</TD><TD width=99.6><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>36,138&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(36,138)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Other investing activities</P>
</TD><TD width=99.6><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(190,899)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>66,021&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Net cash used in investing activities</P>
</TD><TD style="border-top:1px solid #000000" width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(207,748)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000" width=99.667 colspan=2><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(6,172)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Cash flows from financing activities:</P>
</TD><TD width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Payments on long-term debt</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(487)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(447)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Other financing activities</P>
</TD><TD style="border-bottom:1px solid #000000" width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>10,649&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>1,737&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Net cash provided by financing activities</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>10,162&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>1,290&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Effect of exchange rate changes on cash </P>
</TD><TD style="border-bottom:1px solid #000000" width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>6,248&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(2,420)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Net (decrease) increase in cash and cash equivalents</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(73,109)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>100,982&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Cash and cash equivalents at beginning of period</P>
</TD><TD style="border-bottom:1px solid #000000" width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>296,716&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>195,734&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Cash and cash equivalents at end of period</P>
</TD><TD style="border-bottom:2.667px double #000000" width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;223,607&nbsp;</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;296,716&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Reconciliation of net income to net cash provided by operating activities:</P>
</TD><TD valign=top width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Net Income</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;103,263&nbsp;</P>
</TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;81,553&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Adjustments to reconcile net income to net cash provided by</P>
</TD><TD width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">operating activities (net of effects of acquisitions):</P>
</TD><TD width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Depreciation and amortization</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>55,414&nbsp;</P>
</TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>60,974&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">&nbsp;&nbsp;&nbsp;Impairment expense</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>19,770&nbsp;</P>
</TD></TR>
<TR><TD width=406.467><P style="line-height:12px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Changes in working capital </P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(9,026)</P>
</TD><TD width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(31,599)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Litigation settlement related to MJ acquisition</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>(46,981)</P>
</TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>--&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; text-indent:9.6px; font-family:Arial; font-size:12px">Other</P>
</TD><TD width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>15,559&nbsp;</P>
</TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>(22,414)</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000" width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:1px solid #000000" width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=406.467><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px">Net cash provided by operating activities</P>
</TD><TD style="border-bottom:2.667px double #000000" width=99.6><P style="line-height:12px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;118,229&nbsp;</P>
</TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:2.667px double #000000" width=99.667 colspan=2><P style="line-height:14.667px; margin:0px; font-family:Arial; font-size:12px" align=right>$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;108,284&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=406.467><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=99.6><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=15.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=99.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
</DIV></BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
